MUC1 is a novel marker for the type II pneumocyte lineage during lung carcinogenesis

Cancer Research

Volumn 58, Issue 23, 1998, Pages 5582-5589

  Jarrard, Julia A ^a   Linnoila, R Ilona ^a   Lee, HyeRan ^a   Steinberg, Seth M ^b   Witschi, Hanspeter ^c   Szabo, Eva ^a  

^a Division of Clinical Sciences   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; HISTONE DEACETYLASE; MESSENGER RNA; MUCIN; TUMOR MARKER;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HAMSTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; LUNG ALVEOLUS CELL TYPE 2; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CA-15-3 ANTIGEN; CARCINOGENS; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIFFERENTIATION; CELL LINEAGE; CRICETINAE; DOWN-REGULATION; FEMALE; HISTONE DEACETYLASES; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; LUNG NEOPLASMS; MALE; MESOCRICETUS; MIDDLE AGED; NITROSAMINES; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PULMONARY ALVEOLI; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 0032401838     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Rose, M. C. Mucins: structure, function, and role in pulmonary diseases. Am. J. Physiol., 263: L413-L429, 1992.
2. Patton, S., Gendler, S., and Spicer, A. The epithelial mucin, MUC1 of milk, mammary gland and other tissues. Biochim. Biophys. Acta, 1241: 407-424, 1995.
3. Gendler, S., and Spicer, A. Epithelial mucin genes. Annu. Rev. Physiol., 57: 607-634, 1995.
4. Abe, M., and Kufe, D. Structural analysis of the DF3 human breast carcinoma-associated protein. Cancer Res., 49: 2834-2839, 1989.
5. Ho, S., Niehans, G., Lyftogt, C., Yan, P., Cherwitz, D., and Gum, E. Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res., 53: 641-651, 1993.
6. Finkbeiner, W., Carrier, S., and Teresi, C. Reverse transcription-polymerase chain reaction phenotypic analysis of cell cultures of human tracheal epithelium, tracheo-bronchial glands, and lung carcinomas. Am. J. Respir. Cell Mol. Biol., 9: 547-556, 1993.
7. Chambers, J., Hollingsworth, M., Trezise, A., and Harris, A. Developmental expression of mucin genes MUC1 and MUC2. J. Cell Sci., 107: 413-424, 1994.
8. Ho, S., Shekels, L., Toribara, N., Young, K., Lyftogt, C., Cherwitz, D., and Niehans, G. Mucin gene expression in normal, preneoplastic, and neoplastic human gastric epithelium. Cancer Res., 55: 2681-2690, 1995.
9. Dahiya, R., Kwak, K., Ho, S., Yoon, W., and Kim, Y. Cystic fibrosis and pancreatic cancer cells synthesize and secrete MUC1 type mucin. Biochem. Mol. Biol. Int., 35: 351-362, 1995.
10. Nguyen, P., Niehans, G., Cherwitz, D., Kim, Y., and Ho, S. Membrane-bound (MUC1) and secretory (MUC2, MUC3, and MUC4) mucin gene expression in human lung cancer. Tumor Biol., 17: 176-192, 1996.
11. Seregni, E., Botti, C., Lombardo, C., Cantoni, A., Bogni, A., Cataldo, I., and Bombardieri, E. Pattern of mucin gene expression in normal and neoplastic lung tissues. Anticancer Res., 16: 2209-2214, 1996.
12. Voynow, J., and Rose, M. Quantitation of mucin mRNA in respiratory and intestinal epithelial cells. Am. J. Respir. Cell Mol. Biol., 11: 742-750, 1994.
13. Sasaki, M., Nakanuma, Y., and Kim, Y. Characterization of apomucin expression in intrahepatic cholangiocarcinomas and their precursor lesions: an immunohistochemical study. Hepatology, 24: 1074-1078, 1996.
14. Ajioka, Y., Allison, L., and Jass, J. Significance of MUC1 and MUC2 mucin expression in colorectal cancer. J. Clin. Pathol., 49: 560-564, 1996.
15. Dahiya, R., Kwak, K., Byrd, J., Ho, S., Yoon, W., and Kim, Y. Mucin synthesis and secretion in various human epithelial cancer cell lines that express the MUC-1 mucin gene. Cancer Res., 53: 1437-1443, 1993.
16. Yu, C., Yang, P., Shew, J., Hong, T., Yang, S., Lee, Y., Lee, L., Luh, K., and Wu, C. Mucin mRNA expression in lung adenocarcinoma cell lines and tissues. Oncology, 53: 118-126, 1996.
17. Hull, S., Bright, A., Carraway, K., Abe, M., Hayes, D., and Kufe, D. Oligosaccharide differences in the DF3 sialomucin antigen from normal human mild and the BT-20 human breast carcinoma cell line. Cancer Commun., 1: 261-267, 1989.
18. Dong, Y., Walsh, M., Cummings, M., Wright, R., Khoo, S., Parsons, P., and McGuckin, M. Expression of MUC1 and MUC2 mucins in epithelial ovarian tumors. J. Pathol., 183: 311-317, 1997.
19. Wesseling, J., van der Valk, S., and Hilkens, J. A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. Mol. Biol. Cell, 7: 565-577, 1996.
20. Hilkens, J., Wesseling, J., Vos, H. L., Storm, J., Boer, B., van der Valk, S, W., and Maas, M. C. E. Involvement of the cell surface-bound mucin, episialin/MUC1, in progression of human carcinomas. Biochem. Soc. Transact., 23: 822-826, 1995.
21. Kondo, K., Kohno, N., Yokoyama, A., and Hiwada, K. Decreased MUC1 expression induces E-cadherin-mediated cell adhesion of breast cancer cell lines. Cancer Res., 58: 2014-2019, 1998.
22. Agrawal, B., Krantz, M., Reddish, M., and Longenecker, B. Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2. Nat. Med., 4: 43-49, 1998.
23. Pandy, P., Kharbanda, S., and Kufe, D. Association of the DF3/MUC1 breast cancer antigen with Grb2 and the Sos/Ras exchange protein. Cancer Res., 55: 4000-4003, 1995.
24. Romero, S., Fernandez, C., Arriero, J., Espasa. A., Candela, A., Martin, C., and Sanchez-Paya, J. CEA, CA 15-3, and CYFRA 21-1 in serum and pleural fluid of patients with pleural effusions. Eur. Respir. J., 9: 17-23, 1996.
25. Vizcarra, E., Lluch, A., Cibrian, R., Jarque, F., Alberola, V., Belloch, V., and Garcia-Conde, J. Value of CA 15.3 in breast cancer and comparison with CEA and TPA: a study of specificity in disease-free follow-up patients and sensitivity in patients at diagnosis of the first metastasis. Breast Cancer Res. Treat., 37: 209-216, 1996.
26. Pectasides, D., Pavlidis, N., Gogou, L., Antoniou, F., Nicolaides, C., Tsikalakis, D., and Fountzilas, G. Clinical value of CA 15-3, mucin-like carcinoma-associated antigen, tumor polypeptide antigen, and carcinoembryonic antigen in monitoring early breast cancer patients. Am. J. Clin. Oncol., 19: 459-464, 1996.
27. von Mensdorff-Pouilly, S., Gourevitch, M. M., Kenemans, P., Verstraeten, A. A., Litvinov, S. V., van Kamp, G. J., Meijer, S., Vermorken, J., and Hilgers, J. Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumors. Eur. J. Cancer, 32A: 1325-1331, 1996.
28. Katayose, Y., Kudo, T., Suzuki, M., Shinoda, M., Saijyo, S., Sakurai, N., Saeki, H., Fukuhara, K., Imai, K., and Matsuno, S. MUC1-speciftc targeting immunotherapy with bispecific antibodies: inhibition of xenografted human bile duct carcinoma growth. Cancer Res., 50: 4205-4212, 1996.
29. Apostolopoulos, V., Osinski, C., and McKenzie, I. MUC1 cross-reactive Ga1α(1,3)Ga1 antibodies in humans switch immune responses from cellular to humoral. Nat. Med., 3: 315-320, 1998.
30. Chen, L., Chen, D., Manome, Y., Dong, Y., Fine, H., and Kufe, D. Breast cancer selective gene expression and therapy mediated by recombinant adenovirus containing the DF3/MUC1 promoter. J. Clin. Invest., 96: 2775-2782, 1995.
31. Adamson, I. Y. R., and Bowden, D. H. The type 2 cell as progenitor of alveolar epithelial regeneration. A cytodynamic study in mice after exposure to oxygen. Lab. Invest., 30: 35-42, 1974.
32. Plopper, C. G., and Dunworth, D. L. Structure, function, cell injury, and cell renewal of bronchiolar-alveolar epithelium. In: E. M. McDowell (ed.), Lung Carcinomas, pp. 94-128. New York: Churchill Livingstone, 1987.
33. Mitzutani, Y., Nakajima, T., Morinaga, S., Gotoh, M., Shimosato, Y., Akino, T., and Suzuki, A. Immunohistochemical localization of pulmonary surfactant apoproteins in various lung tumors. Cancer (Phila.), 61: 532-537, 1988.
34. Linnoila, R. I., Mulshine, J. L., Steinberg, S. M., and Gazdar, A. F. Expression of surfactant-associated protein in non-small cell lung cancer: a discriminant between biologic subsets. J. Natl. Cancer Inst. Monogr., 13: 61-66, 1992.
35. Szabo, E., Riffe, M. E., Steinberg, S. M., Birrer, M. J., and Linnoila, R. I. Altered cJUN Expression: an early event in human lung carcinogenesis (Lond.). Cancer Res., 56: 305-315, 1996.
36. Shaw, G. L., Gazdar, A. F., Phelps, R., Linnoila, R. I., Ihde, D. C., Johnson, B. E., Oie, H. K., Pass, H. I., Steinberg, S. M., Ghosh, B. C., Walsh, T. E., Nesbitt, J. C., Cotelingham, J. D., Minna, J. D., and Mulshine, J. L. Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug sensitivity testing. Cancer Res., 53: 5181-5187, 1993.
37. Linnoila, R. I., Piantadosi, S., and Ruckdeschel, J. C. Impact of neuroendocrine differentiation in non-small cell lung cancer, the LCSG experience. Chest, 106 (Suppl.): 367s-371s, 1994.
38. Mantel, N. Chi-square tests with one degree of freedom: extensions of the Mantel-Haenszel procedure. J. Am. Stat. Assoc., 58: 690-700, 1963.
39. Lehmann, E. Nonparametrics: statistical methods based on ranks, pp. 306-309. San Francisco: Holden-Day, 1975.
40. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
41. Mantel, N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep., 50: 163-170, 1966.
42. Sunday, M. E., Willett, C. G., Graham, S. A., Oreffo, V. I. C., Linnoila, R. I., and Witschi, H. Histochemical characterization of non-neuroendocrine tumors and neuroendocrine cell hyperplasia induced in hamster lung by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone with or without hyperoxia. Am. J. Pathol., 147: 740-752, 1995.
43. Park, H., Hyun, S. W., and Kim, K. C. Expression of MUC1 mucin gene by hamster tracheal surface epithelial cells in primary culture. Am. J. Respir. Cell Mol. Biol., 15: 237-244, 1996.
44. r 35,000 surfactant-associated protein in fetal lung. J. Biol. Chem., 262: 7908-7913, 1987.
45. Szabo, E., Goheer, A., Witschi, H., and Linnoila, R. I. Overexpression of CC10 modifies neoplastic potential in lung cancer cells. Cell Growth Differ., 9: 475-485, 1998.
46. Ebina, M., Steinberg, S., Mulshine, J., and Linnoila, R. I. Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer. Cancer Res., 54: 2496-2503, 1994.
47. Jensen, S. M., Kurita, Y., Oie, H., Gazdar, A. F., and Linnoila R. I. Detection of peripheral airway cell differentiation in human lung cancer cell lines by RNA-RNA in situ hybridization with ultrastructural correlation. Proc. Am. Assoc. Cancer Res., 32: 33, 1991.
48. Lee, H. R., Cabanes, A., Senderowicz, A. M., and Szabo, E. Sequential inhibition of cdk2 and cdk4 kinase activities during differentiation in non-small cell lung cancer. Proc. Am. Assoc. Cancer Res., 39: 444, 1998.
49. Hoshikawa, Y., Kwon, H. J., Yoshida, M., Horinouchi, S., and Beppu T. Trichostatin A induces morphological changes and gelsolin expression by inhibiting histone deacetylase in human carcinoma cell lines. Exp. Cell Res., 214: 189-197, 1994.
50. Willsher P. C., Xing, P., Clarke, C. P., Ho, D. W. M., and McKenzie, I. F. C. Mucin 1 anligens in the serum and bronchial lavage fluid of patients with lung cancer. Cancer (Phila.), 72: 2936-2942, 1993.
51. Price, M. R., Rye, P. D., Petrakou, E., et al. Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. Tumor Biol., 19 (Suppl.) 1-20, 1998.
52. Broers, J. L. V., Jensen, S. M., Travis, W. D., Pass, H., Whitsett, J. A., Singh, G., Katyal, S. L., Gazdar, A. F., Minna, J. D., and Linnoila, R. I. Expression of surfactant associated protein-A and Clara cell 10 kilodalton mRNA in neoplastic and non-neoplastic human lung tissue as detected by in situ hybridization. Lab. Invest., 66: 317-346, 1992.
53. Spicer, A., Rowse, G., Lidner, T., and Gendler, S. Delayed mammary tumor progression in Muc-1 null mice. J. Biol. Chem., 270: 30093-30101, 1995.
54. Gollub, E., Goswami, S., Kouba, D., and Marom, Z. Regulation of mucin gene expression in secretory epithelial cells. Biochem. Biophys. Res. Commun., 197: 667-673, 1993.
55. Lesuffleur, T., Porchet, N., Aubert, J. P., Swallow, D., Gum, J. R., Kim, Y. S., Real, F. X., and Zweibaum, A. Differential expression of the human mucin genes MUC1 to MUC5 in relation to growth and differentiation of different mucus-secreting HT-29 cell subpopulations. J. Cell Sci., 106: 771-783, 1993.
56. Guzman, K., Bader, T., and Nettesheim, P. Regulation of MUC5 and MUC1 gene expression: correlation with airway mucous differentiation. Am. J. Physiol., 270: L846-L853, 1996.
57. Lambrechts, M. G., Bauer, F. F., Marmur, J., and Pretorius, I. S. Muc1, a mucin-like protein that is regulated by Mss10, is critical for pseudohyphal differentiation in yeast. Proc. Natl. Acad. Sci. USA, 93: 8419-8424, 1996.
58. Dosaka-Akita, H., Hommura, F., Fujita, H., Kinoshita, I., Nishi, M., Morikawa, T., Katoh, H., Kawakami, Y., and Kuzumaki, N. Frequent loss of gelsolin expression in non-small cell lung cancers of heavy smokers. Cancer Res., 58: 322-327, 1998.
59. Perey, L., Hayes, D., and Kufe, D. Effects of differentiating agents on cell surface expression of the breast carcinoma-associated DF3-P epitope. Cancer Res., 52: 6365-6370, 1992.
60. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer statistics, 1997. CA Cancer J. Clin., 47: 5-27, 1997.